Literature DB >> 8072283

The use of local and systemic antibiotics in rat fecal peritonitis.

P W Perdue1, K K Kazarian, J Nevola, W R Law, T Williams.   

Abstract

Treatment of fecal peritonitis includes administration of antibiotics, physical removal of contaminants, and restoration of gastrointestinal integrity. The temporal relationship of parenteral antibiotics and peritoneal irrigation with varied antibiotic solutions was studied in a peritonitis model. Antibiotics in high concentrations may actually inhibit host immune cells; therefore, dilute solutions used were MIC (minimum inhibitory concentration) (micrograms per millimeter) equivalent to usually achieved standard therapeutic blood levels. Sprague-Dawley rats were given a quantitative intraperitoneal challenge of 2 x 10(10) CFU/kg Escherichia coli and 10 mg autoclaved rat feces. Rats were randomized to receive 30 mg/kg intramuscular ceftriaxone (CTRX) either at the time of challenge (T = 0) or 2 hr later (T = 2). Two hours after peritonitis, rats received peritoneal irrigation with 30 cc of (1) normal saline, (2) dilute (10 mg/liter) CTRX solution, or (3) concentrated (1000 mg/liter) CTRX solution or (4) no irrigation. Survival and intraperitoneal pathology were then assessed. Parenteral CTRX given concurrently with peritoneal contamination improved survival (67%) compared with parenteral administration given 2 hr later (33%) (P < 0.05). Intraperitoneal CTRX irrigation improved survival (100%) in animals that received parenteral CTRX concurrently with contamination; this beneficial effect was present with both dilute and concentrated solutions and was significantly better than saline irrigation alone. Parenteral antibiotics given early after contamination of the peritoneum associated later with peritoneal lavage with antibiotic solutions improved survival.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8072283     DOI: 10.1006/jsre.1994.1155

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

1.  Effect of intraperitoneal application of an endotoxin inhibitor on survival time in a laparoscopic model of peritonitis in rats.

Authors:  Roger Kuhn; Daniel Schubert; Joerg Tautenhahn; Gerd Nestler; Hans-Ulrich Schulz; Maike Bartelmann; Hans Lippert; Matthias Pross
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

2.  Preconditioning with ozone/oxygen mixture induces reversion of some indicators of oxidative stress and prevents organic damage in rats with fecal peritonitis.

Authors:  Zullyt Zamora Rodríguez; Dailén Guanche; Ricardo González Alvarez; Frank Hernández Rosales; Yaima Alonso; Siegfried Schulz
Journal:  Inflamm Res       Date:  2009-03-10       Impact factor: 4.575

3.  Catheterization of the carotid artery and jugular vein to perform hemodynamic measures, infusions and blood sampling in a conscious rat model.

Authors:  Jing Feng; Yvonne Fitz; Yan Li; Melinda Fernandez; Irene Cortes Puch; Dong Wang; Stephanie Pazniokas; Brandon Bucher; Xizhong Cui; Steven B Solomon
Journal:  J Vis Exp       Date:  2015-01-30       Impact factor: 1.355

4.  The effectiveness of pedicle screw immersion in vancomycin and ceftriaxone solution for the prevention of postoperative spinal infection: A prospective comparative study.

Authors:  Burak Eren; Feyza Karagöz Güzey; Serkan Kitiş; Nezih Özkan; Cafer Korkut
Journal:  Acta Orthop Traumatol Turc       Date:  2018-06-07       Impact factor: 1.511

5.  Zymosan-induced luminol-dependent chemiluminescence response of circulating and extravasated leukocytes in experimental sepsis.

Authors:  Haseeb Ahmad Khan
Journal:  Mediators Inflamm       Date:  2004-04       Impact factor: 4.711

6.  Irrigation of abdomen with imipenem solution decreases surgical site infections in patients with perforated appendicitis: a randomized clinical trial.

Authors:  Mohammad Ali Hesami; Hamid Alipour; Hamed Nikoupour Daylami; Bijan Alipour; Shahrzad Bazargan-Hejazi; Alireza Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2014-04-05       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.